BlackRock Institutional Trust’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$8.86M Buy
623,889
+9,224
+2% +$143K ﹤0.01% 2462
2016
Q3
$10.8M Buy
614,665
+6,751
+1% +$112K ﹤0.01% 2296
2016
Q2
$10.4M Sell
607,914
-5,177
-0.8% -$92.5K ﹤0.01% 2271
2016
Q1
$12.1M Buy
613,091
+4,196
+0.7% +$67.3K ﹤0.01% 2143
2015
Q4
$11.6M Buy
608,895
+8,407
+1% +$171K ﹤0.01% 2232
2015
Q3
$11.5M Sell
600,488
-13,164
-2% -$447K ﹤0.01% 2197
2015
Q2
$28.5M Sell
613,652
-33,715
-5% -$1.46M ﹤0.01% 1673
2015
Q1
$28.3M Buy
647,367
+23,553
+4% +$1.09M ﹤0.01% 1715
2014
Q4
$21.6M Buy
623,814
+17,877
+3% +$726K ﹤0.01% 1848
2014
Q3
$25.4M Sell
605,937
-4,974
-0.8% -$222K ﹤0.01% 1732
2014
Q2
$35.8M Sell
610,911
-7,923
-1% -$499K 0.01% 1554
2014
Q1
$39M Buy
618,834
+14,400
+2% +$955K 0.01% 1474
2013
Q4
$35.4M Sell
604,434
-26,203
-4% -$1.37M 0.01% 1517
2013
Q3
$33.2M Buy
630,637
+8,721
+1% +$586K 0.01% 1484
2013
Q2
$47.9M Buy
+621,916
New +$50.8M 0.01% 1177

Other funds holding ARNA

BlackRock Institutional Trust's ARNA Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Arena Pharmaceuticals Inc (ARNA) stake by 1.5% in Q4 2016, buying an estimated $143K and bringing the position to 623,889 shares worth $8.86M. The position accounts for ﹤0.01% of the portfolio, ranked #2462.

BlackRock Institutional Trust first reported a position in ARNA in Q2 2013 and has held it in 15 quarters since. The position peaked at $47.9M in Q2 2013. 128 funds tracked by Wall St. Rank hold ARNA as of Q4 2016.

  • BlackRock Institutional Trust held 623,889 shares of Arena Pharmaceuticals Inc worth $8.86M as of Q4 2016.
  • BlackRock Institutional Trust bought 9,224 Arena Pharmaceuticals Inc shares in Q4 2016, an estimated $143K.
  • Arena Pharmaceuticals Inc made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2462 holding.
  • BlackRock Institutional Trust first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Institutional Trust's Arena Pharmaceuticals Inc position peaked at $47.9M in Q2 2013.
  • 128 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.